AKEBIA THERAPEUTICS, INC. Lessor, Operating Lease, Payment to be Received, after Year Five
AKEBIA THERAPEUTICS, INC. (AKBA) had Lessor, Operating Lease, Payment to be Received, after Year Five of $0 as of 2022-12-31, per its 10-K/A filed 2023-08-28.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter · last filed 2023-08-28
- 2022-12-31: Lessor, Operating Lease, Payment to be Received, after Year Five $0.00.
- 2021-12-31: Lessor, Operating Lease, Payment to be Received, after Year Five $0.00.
- 2020-12-31: Lessor, Operating Lease, Payment to be Received, after Year Five $0.00.
| Period end | Lessor, Operating Lease, Payment to be Received, after Year Five |
|---|---|
| 2022-12-31 | $0.00 10-K/A · filed 2023-08-28 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |